NASDAQ: DXCM
Dexcom Inc Earnings Dates, Reports, Calls

Dexcom earnings were $680.8M for the trailing 12 months ending Sep 30, 2024, with 77.6% growth year over year. The latest DXCM earnings report on Sep 30, 2024 announced Q3 2024 earnings of $134.6M, down 6.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, DXCM reported annual earnings of $541.5M, with 58.7% growth.

DXCM past earnings growth

How has DXCM's earnings growth performed historically?

Company
77.55%
Industry
38.56%
Market
47.91%
DXCM's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DXCM's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DXCM's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DXCM earnings history

Current Revenue
$4.0B
Current Earnings
$680.8M
Current Profit Margin
17.2%

DXCM Return on Equity

Current Company
31.2%
Current Industry
11.4%
Current Market
35%
DXCM's Return on Equity (31.2%)... subscribe to Premium to read more.
High Return on Equity Performance

DXCM Return on Assets

Current Company
10.5%
Current Industry
6.6%
DXCM is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DXCM announces earnings.

DXCM Return on Capital Employed

Current Company
16.21%
Current Industry
8.8%
DXCM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DXCM vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DXCM$961.20M$680.80M+29.43%$1.74
EW$4.53B$4.16B+41.05%$6.94
PHG$1.18B-$501.08MN/A-$0.55
STE$1.22B$434.80M+2.08%$4.40
ZBH$2.21B$1.08B+69.39%$5.27

Dexcom Earnings Reports & History FAQ

What were Dexcom's earnings last quarter?

On DXCM's earnings call on Invalid Date, Dexcom (NASDAQ: DXCM) reported Q3 2024 earnings per share (EPS) of $0.34, up 9.68% year over year. Total DXCM earnings for the quarter were $134.60 million. In the same quarter last year, Dexcom's earnings per share (EPS) was $0.31.

If you're new to stock investing, here's how to buy Dexcom stock.

Is Dexcom profitable or losing money?

As of the last Dexcom earnings report, Dexcom is currently profitable. Dexcom's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $680.80 million, a 80.58% increase year over year.

What was DXCM's earnings growth in the past year?

As of Dexcom's earnings date in Invalid Date, Dexcom's earnings has grown 77.55% year over year. This is 38.99 percentage points higher than the US Medical Devices industry earnings growth rate of 38.56%. DXCM earnings in the past year totalled $680.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.